Source: ERJ Open Res, 7 (1) 00394-2020; 10.1183/23120541.00394-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michael D. Kim, Nathalie Baumlin, John S. Dennis, Makoto Yoshida, Adrian Kis, Carolina Aguiar, Andreas Schmid, Eliana Mendes, Matthias Salathe. Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion. ERJ Open Res, 7 (1) 00394-2020; 10.1183/23120541.00394-2020

Member's Comments

No comment yet.

Related content which might interest you: Tiotropium inhalation prevents acute cigarette smoke-induced airway inflammation in mice Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation Source: Eur Respir J 2015; 45: 1669-1680 Year: 2015 LPS accelerates cigarette smoke-induced deterioration in respiratory function and airway inflammation in mice Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007 Role of activin-A in cigarette smoke-induced inflammation and COPD Source: Eur Respir J 2014; 43: 1028-1041 Year: 2014 Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Tobacco smoking alters the relationship between airway inflammation and airway hyperresponsiveness in asthma Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012 LSC Abstract – Cigarette smoke exposure accelerates airway mucus accumulation and inflammation in ENaC-overexpressed mice Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Resistive breathing aggravates cigarette smoke-induced pulmonary inflammation. Source: International Congress 2017 – Smoking and molecular findings Year: 2017 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2014; 43: 1211-1212 Year: 2014 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2014; 43: 1208-1211 Year: 2014 Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy Source: Eur Respir J 2013; 42: 350-361 Year: 2013 Cigarette smoking inhibits LTA4H aminopeptidase activity and contributes to chronic neutrophilic airway inflammation and COPD Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice Source: Eur Respir J 2002; 20: Suppl. 38, 310s Year: 2002 Effect of sildenafil on mucus hypersecretion of rat airway Source: Eur Respir J 2007; 30: Suppl. 51, 523s Year: 2007 Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD Source: Eur Respir J 2004; 24: 391-396 Year: 2004 Cigarette smoke-induced airway neurogenic inflammation is mediated by α,ß-unsaturated aldehydes and the TRPA1 receptor. Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008 Pioglitazone inhibits obesity-related airway hyperreactivity Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 Inhaled insulin does not trigger lung inflammation and airway remodelling Source: Eur Respir J 2009; 33: 444-445 Year: 2009